Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H20O5 |
| Molecular Weight | 340.3698 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC=C1O)C2=C(C)C(C)=C(O2)C3=CC=C(O)C(OC)=C3
InChI
InChIKey=OIXPKFRMEUTHOG-UHFFFAOYSA-N
InChI=1S/C20H20O5/c1-11-12(2)20(14-6-8-16(22)18(10-14)24-4)25-19(11)13-5-7-15(21)17(9-13)23-3/h5-10,21-22H,1-4H3
| Molecular Formula | C20H20O5 |
| Molecular Weight | 340.3698 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Furoguaiacin (aka alpha-Guaiaconic acid) is a component of guaiac resin which can be obtained from the tropical trees Guajacum officinale and Guajacum sanctum. Furoguaiacin has been used as chromogenic sensor for the detection of occult blood in fecal matter. Furoguiacin has potential anti-inflammatory properties highlighted by its ability to suppress NO production in IL-1B treated hepatocytes.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0002537 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27709321 |
36.1 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Lignans from guaiac resin decrease nitric oxide production in interleukin 1β-treated hepatocytes. | 2017-01 |
|
| Anti-angiogenic activity of arachidonic acid metabolism inhibitors in angiogenesis model systems involving human microvascular endothelial cells and neovascularization in mice. | 1993-10-21 |
|
| False-positive guaiac testing with iodine. | 1985-05 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27709321
Hepatocytes were isolated from rat liver by collagenase perfusion and re-suspended in Williams' E medium (WE). Cells were incubated overnight at 37 deg-C then treated with 1 nM rat IL-1B and Furoguaiacin (up to 75 microM) for 8 hours. Nitrous Oxide production was indirectly measured using the Griess method and directly by adding 20 microM NaNO2 and monitoring the quenching of nitrite. Furoguiacin was found to inhibit IL-1B induced NO production with an IC50 of 36.1 microM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:58:41 GMT 2025
by
admin
on
Mon Mar 31 19:58:41 GMT 2025
|
| Record UNII |
B92R7Z78ZX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
B92R7Z78ZX
Created by
admin on Mon Mar 31 19:58:41 GMT 2025 , Edited by admin on Mon Mar 31 19:58:41 GMT 2025
|
PRIMARY | |||
|
10035-27-5
Created by
admin on Mon Mar 31 19:58:41 GMT 2025 , Edited by admin on Mon Mar 31 19:58:41 GMT 2025
|
PRIMARY | |||
|
DTXSID70143231
Created by
admin on Mon Mar 31 19:58:41 GMT 2025 , Edited by admin on Mon Mar 31 19:58:41 GMT 2025
|
PRIMARY | |||
|
165795
Created by
admin on Mon Mar 31 19:58:41 GMT 2025 , Edited by admin on Mon Mar 31 19:58:41 GMT 2025
|
PRIMARY |